<p>Numbers reflect total number of genes as well as the number up- and down-regulated. These numbers were derived from a slightly larger number of probe sets. Unannotated probe sets are not included in this tabulation. BL = baseline, HC = healthy control (n = 19), Dx = disease. Numbers are based on general linear model with p<.05 and fold change at least 1.5.</p><p>Numbers of significant genes in PBMC comparisons.</p
<p>We compared the levels of expression of 15,861 genes with nonzero expression levels in both liver...
<p>Number of significant differentially expressed genes within each comparative microarray group (fi...
<p>Genes are ordered by maximum fold change from baseline. For two or more probesets annotated to th...
<p>Numbers reflect total number of genes as well as the number up- and down-regulated. These numbers...
<p>The proportion of differentially expressed genes in PBMC in relation to (a) the number selected o...
<p>Genes have been grouped according to the number of data sets in which they displayed significant ...
<p>Shown are the number of differentially expressed genes and the average fold changes of regulated ...
<p>Table shows numbers of unique genes.</p>*<p> = significantly overrepresented (Bonferroni correcte...
<p>Number of gene markers significantly correlated with response to different drugs identified by PC...
<p>Representative genes and average PGS fold change (across multiple probes) from the top 100 for ca...
<p>The number of genes found to be up- and down-regulated in the preeclamptics of each cluster compa...
<p>Note: Significance level is 0.01, not corrected for muliple testing. The analyses of the first tw...
a) data with n = 10–11 samples in each group and b) randomly selected n = 3 samples in each group.</...
<p>The three shaded bars emanating from the center each represent a list of significant probe sets w...
<p>Number of genes (Real Set) with S-score >2 or <−2 in the 138 cancer gene list from Volgestein et ...
<p>We compared the levels of expression of 15,861 genes with nonzero expression levels in both liver...
<p>Number of significant differentially expressed genes within each comparative microarray group (fi...
<p>Genes are ordered by maximum fold change from baseline. For two or more probesets annotated to th...
<p>Numbers reflect total number of genes as well as the number up- and down-regulated. These numbers...
<p>The proportion of differentially expressed genes in PBMC in relation to (a) the number selected o...
<p>Genes have been grouped according to the number of data sets in which they displayed significant ...
<p>Shown are the number of differentially expressed genes and the average fold changes of regulated ...
<p>Table shows numbers of unique genes.</p>*<p> = significantly overrepresented (Bonferroni correcte...
<p>Number of gene markers significantly correlated with response to different drugs identified by PC...
<p>Representative genes and average PGS fold change (across multiple probes) from the top 100 for ca...
<p>The number of genes found to be up- and down-regulated in the preeclamptics of each cluster compa...
<p>Note: Significance level is 0.01, not corrected for muliple testing. The analyses of the first tw...
a) data with n = 10–11 samples in each group and b) randomly selected n = 3 samples in each group.</...
<p>The three shaded bars emanating from the center each represent a list of significant probe sets w...
<p>Number of genes (Real Set) with S-score >2 or <−2 in the 138 cancer gene list from Volgestein et ...
<p>We compared the levels of expression of 15,861 genes with nonzero expression levels in both liver...
<p>Number of significant differentially expressed genes within each comparative microarray group (fi...
<p>Genes are ordered by maximum fold change from baseline. For two or more probesets annotated to th...